Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures (Q40631162)

22 September 2017

title

Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures (English)

1 reference

22 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

14 March 2024

author name string

Fumiaki Itoh

1

1 reference

22 September 2017

Shigemi Aoyagi

2

1 reference

22 September 2017

Hanako Furihata-Komatsu

3

1 reference

22 September 2017

Masato Aoki

4

1 reference

22 September 2017

Hiroshi Kusama

5

1 reference

22 September 2017

Masami Kojima

6

1 reference

22 September 2017

Hiroshi Kogo

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

22 September 2017

5 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14512092

full work available at URL

14 March 2024

https://api.elsevier.com/content/article/PII:S0014299903022052?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

https://api.elsevier.com/content/article/PII:S0014299903022052?httpAccept=text/plain

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

European Journal of Pharmacology

14 March 2024

published in

1 reference

22 September 2017

volume

477

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

9-16

1 reference

Etidronate (HEBP) promotes osteoblast differentiation and wound closure in rat calvaria

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

A general peptide substrate for protein tyrosine phosphatases

14 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

An investigation of the substrate specificity of protein phosphatase 2C using synthetic peptide substrates; comparison with protein phosphatase 2A

14 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Human protein tyrosine phosphatase-sigma: alternative splicing and inhibition by bisphosphonates

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Incadronate and etidronate accelerate phosphate-primed mineralization of MC4 cells via ERK1/2-Cbfa1 signaling pathway in a Ras-independent manner: further involvement of mevalonate-pathway blockade for incadronate

14 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Rapid intracellular degradation of newly synthesized collagen by bone cells Effect of dichloromethylenebisphosphonate

14 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Effects of bisphosphonates APD and HEBP on bone metabolism in vitro

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

The effects of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on collagen synthesis by rabbit articular chondrocytes and rat bone cells

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Histochemical demonstration of enzyme activities in plastic and paraffin embedded tissue sections

14 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1.

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Okadaic acid enhances prostaglandin E1-induced alkaline phosphatase activity in osteoblast-like cells: regulation at a point downstream from protein kinase A

14 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Treatment effects of bisphosphonates on ovariectomy-induced osteopenia in rats: comparison between clodronate and etidronate

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate

14 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Timing of food intake has a marked effect on the bioavailability of clodronate

14 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts.

14 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Alendronate inhibition of protein-tyrosine-phosphatase-meg1

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

14 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.

14 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Bisphosphonates in the treatment of metabolic bone diseases

14 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Bisphosphonates: from the laboratory to the clinic and back again

14 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate

14 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells

14 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro

14 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Alendronate modulates osteogenesis of human osteoblastic cells in vitro

14 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

In vitro effect of KCA-098, a derivative of coumestrol, on bone resorption of fetal rat femurs

14 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

14 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption

14 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Okadaic acid reverses the inhibitory effect of protein kinase C on alkaline phosphatase activity in osteoblast-like cells

14 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells

14 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

Substrate specificity of the protein tyrosine phosphatases

14 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.011

14 March 2024

Identifiers

1 reference

22 September 2017

1 reference